一个综合的定量系统药理学虚拟人群方法,用于与瘤学疗效终点校准
Nathan Braniff1, Tanvi Joshi2, Tyler Cassidy3
1Pharmacometrics & Systems Pharmacology, Pfizer Inc., La Jolla, California, USA.
CPT: pharmacometrics & systems pharmacology
|November 7, 2024
概括
量化系统药理 (QSP) 模型通过预测患者反应变异性来增强药物开发. 这项研究引入了一种算法,以更好地匹配虚拟人群中的瘤负担和无进展生存率,改善瘤学试验预测.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 量化系统药理 (QSP) 模型对于理解发育过程中药物反应的变化至关重要.
- 在QSP模型中将机械生物标志物与临床终点 (如无进展生存期 (PFS)) 联系起来仍然具有挑战性,特别是在瘤学中.
- 在临床数据中进行审查 (例如,撤回,失去随访) 会使终点匹配复杂化.
研究的目的:
- 为QSP模型开发一个扩展的虚拟人口选择算法.
- 在数据审查的情况下,共同匹配瘤负担动态和时间到事件终点 (无进展生存率).
- 提高QSP模型的预测能力,用于瘤学药物开发.
主要方法:
- 开发了一个扩展的虚拟人口选择算法.
- 该算法使用模拟和校准QSP信号通路模型来说明.
- 该模型与固体瘤中小分子向抑制剂的临床数据相匹配.
主要成果:
- 拟议的算法成功地证明了瘤负担和无进展生存率的联合匹配.
- 该方法通过对临床数据进行模拟和校准来验证.
- 这种方法显示了提高瘤学中QSP模型预测的前景.
结论:
- 开发的算法提供了一个强大的方法,可以将时间到事件的终点集成到QSP虚拟群体中.
- 这种方法可以提高瘤学临床试验,特别是固体瘤的QSP预测的准确性.
- 该方法适用于其他需要生存终点匹配的虚拟人口模拟.
更多相关视频
相关概念视频
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
60
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
60
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
49
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
49
Pharmacokinetic Models: Overview
597
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
597
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
70
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
70
Nonlinear Pharmacokinetics: Overview
285
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
285


